Pharmaceutical

Brii Biosciences and Joincare sign licence agreement for BRII-693

Brii Biosciences and Joincare Pharmaceutical have signed a licence and technology transfer agreement for BRII-693 for MDR/XDR infections.

Jul 5, 2025 - 06:00
Brii Biosciences and Joincare sign licence agreement for BRII-693
Brii Biosciences and Joincare Pharmaceutical have signed a licence and technology transfer agreement for BRII-693 for MDR/XDR infections.
Read the original article

Tags:

Previous Article

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Next Article

Theratechnologies shares surge 25% amid $254m Future Pak takeover

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Japan’s M&A Boom

Japan’s M&A Boom

Apr 16, 2023

CDC to cut back on Covid data it collects as public health emergency ends

CDC to cut back on Covid data it collects as public hea...

May 5, 2023

STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected

STAT+: UnitedHealth’s profit jumps as medical costs com...

Oct 14, 2023